Elite Pharmaceuticals Inc (ELTP)

[Couch]

That's the beauty of Elite's 2 bead ADT technology it can be applied to both branded and generic products. The only thing stopping Elite is having enough capital to do so.

Since Elite has removed its going concern from its SEC filings this allows Elite to access better financing sources who wouldn't touch Elite previously. Too risky.

Watch for Elite to hammer out another financing deal better than the LPC one soon. Elite has enough cash on hand to get through the FDA trails for their first ADT opioid and maybe their second. However, Nasrat is looking at 17 ADT opioids and a better financing deal will be wanted. Elite has the series preferred shares also it can use for this purpose.